Objective: This research established test-retest reliability and construct validity for the Neck Pain and Disability Scale (NPAD).
The Neck Pain and Disability Scale (NPAD) 1 was developed as a comprehensive measure of neck pain. Initial testing of patients with cervical pain showed that the measure had high internal consistency and at least four underlying dimensions: dysfunctional or disabling neck problems, pain intensity, an emotional or affective dimension, and interference in life activities. The value of the NPAD as a specific measure of neck pain was demonstrated when patients with neck pain had significantly higher scores for all NPAD factors in comparison with a similar group of patients with lower back and leg pain. However, no difference between the two groups of pain patients were revealed by more generalized pain and disability measures, such as the Oswestry Disability Questionnaire (ODQ) 2 or the Pain Disability Index (PDI). 3 The NPAD differs from other measures of neck pain, such as the Neck Disability Index (NDI) 4 and the Northwick Park Neck Pain Questionnaire, 5 because it is responsive to the multidimensional nature of the pain experience. Pain is acknowledged to be a complex perceptual experience with a number of underlying factors that include sensory, affective, and intensity dimensions. 6 Because most chronic pain studies consider pain as a single dimension varying only in magnitude, it is relatively unknown whether treatments for chronic pain conditions influence all of the underlying factors to the same degree or are tailored to one or more dimensions.
We were interested in developing a measure that could be used in a clinical setting that would permit a comprehensive assessment of a patient's neck pain. Although the NDI has demonstrated reliability and validity as a disability scale, there is no evidence that it addresses all aspects of the pain experience. In addition, the NDI included 10 items geared toward assessing disability after injury to the cervical spine, and a number of the items were not relevant for our patients. For example, our patients seldom read, drove a car, or had associated headaches.
The purpose of this study was to provide additional evidence of the reliability and validity of the NPAD as a measure of neck pain. This study was designed to establish test-retest reliability and to demonstrate construct validity by comparing performance on the NPAD with other self-reported pain measures (such as the NDI 4 and the PDI 3 ) and with changes in muscle tenderness as measured by pressure algometry. [7] [8] [9] [10] 
MATERIALS AND METHODS

Participants
A total of 83 patients who sought treatment of neck pain at the Charlotte Spine Center participated in this study. All had received treatment previously that they considered inadequate and were not surgical candidates. The first subset of patients with neck pain included 12 men and 21 women whose ages averaged 43 years (standard deviation [SD] ‫ס‬ 13). They were consecutive patients who volunteered to fill out the NPAD on 2 separate days before treatment. The duration of their pain ranged from 3 months to 28 years (mean ‫ס‬ 5.4 years; SD ‫ס‬ 8.3). Neck pain in this sample was attributed to personal injury (27%), motor vehicle accident (40%), and no injury (33%).
The second subset of patients with neck pain were voluntary participants in a double-blind research study 11 to evaluate the safety and efficacy of botulinum toxin and saline injections for the treatment of chronic neck pain. The sample consisted of 38 women and 12 men whose ages averaged 43.6 years (SD ‫ס‬ 10.7). Pain duration ranged from 5 months to 39.5 years (mean ‫ס‬ 8.6 years; SD ‫ס‬ 9.6). The incidence and designations of injury within this sample were as follows: 36%, no injury; 4%, work-related; 40%, auto-related; 14%, personal injury; and 6%, other.
Measures
The NPAD 1 (Fig. 1 ) consists of 20 items that measure problems with the neck, intensity of pain, its interference with functional aspects of living, and the presence and extent of associated emotional factors. Patients respond to each item by marking along a 10-cm scale. Item scores range from 0 to 5, in quarter-point increments.
If a patient placed a mark on the vertical grid, then the solid lines indicated whole points and the dotted lines indicated half-point increments. When a patient marked the space between the vertical grids, one quarter of a point was added to the score. The NPAD score is the sum of the item scores. Factor scores were also calculated by totaling the items that were found in previous work 1 to load heavily on each of the factors. Completion of the NPAD took less than 5 minutes.
The NDI 4 is a 10-item scale that assesses disability after injury to the cervical spine. It is a modified version of the Oswestry Disability Index, 2 which is scored by summing the responses to each item and expressing the NDI score as a percentage of the maximum possible points.
The other well-known and accepted measure of generalized pain and disability is the PDI, 3 which was used for comparison with the NPAD. The PDI consists of 7 items that are summed into a total score ranging from 0 to 70. Both the NDI and the PDI scales are self-reported measures assessing the degree to which pain interferes with activities of daily living. Higher scores correlate with greater disability.
Procedures
Test-retest reliability
Data were extracted from intake and pain questionnaires completed by the patients when they arrived at the clinic and from a follow-up survey conducted within a week of the initial visit. Patients from the first sample completed the NPAD during their initial visit to the clinic and were asked to complete it a second time within a week, either at a follow-up visit to the clinic or by phone. Other variables surveyed included: age, education level, sex, pain duration, and type of injury. A Pearson product moment correlation was calculated between the two sets of NPAD scores, and a reliability coefficient was computed from the squared correlation.
Because the patients in this first group filled out the NPAD twice before any treatment of their neck pain condition, the reliability coefficient would measure the proportion of true variance and would indicate the consistency of the NPAD across repeated administrations with the same sample.
A secondary source of data for consistency between repeated administrations of the NPAD was the patients in the second group, who were in the clinic monthly for 4 months as part of a research study. 11 For the patients in this group, treatment with injections of either saline or botulinum toxin were randomly administered on the first visit only (week 1). Correlations between the NPADs administered during the second, third, and fourth month after treatment provided additional data for assessing the reproducibility of the measure with the same participants. Correlations were calculated for each group separately so that the effects from the time course of the botulinum toxin would be present in only one of the groups. These data included the treatment effect with injections; therefore, they are not as useful as the data from the first sample of patients.
Construct validity
Previous research 1 has already demonstrated that the NPAD correlates highly with other measures of pain and disability. The focus of this study was to show that the NPAD was an accurate measure of the degree of pain and disability experienced by patients with cervical pain and that it provided an effective way of assessing changes after treatment.
If the NPAD was an accurate indicator of a patient's pain and disability, then changes in the NPAD after treatment with therapeutic injections were expected to correlate with the patient's and physician's global assessment score (GAS) for improvement. The patient's GAS and physician's GAS were measured independently on a scale that ranged from −4 (100% worse) to +4 (100% improvement), with each interval representing a 25% change in condition.
The changes in the NPAD after treatment were also expected to be correlated with changes in muscle tenderness, as measured by a spring-loaded pressure algometer. 7-10 Pressure threshold measurements (kg/cm 2 ) were taken on nontender muscles to serve as controls and then at symptomatic trigger points. A score was calculated by taking the difference between the algometer scores of the control and the score at the most tender trigger point.
In addition, evidence of convergent and divergent validity was obtained by separating the algometer scores at control and trigger points and correlating each with the NPAD changes after treatment. Patients who benefit from the treatment should have reduced scores on the NPAD, and those changes were expected to be correlated with an ability to withstand more pressure on the primary trigger point. Changes in NPAD scores, however, were not expected to be correlated with changes in algometer scores taken at control points.
Furthermore, because the NPAD was designed as a comprehensive instrument, it was expected to provide a more responsive measure of treatment effects than other pain measures such as the NDI and the PDI. Cohen's d test was used to measure treatment effect size for each of the outcome variables. The Neck Pain and Disability Scale factor scores were also calculated to determine whether the treatment influenced the patient's perception of pain in general or had an effect that was specific to one or more of the four underlying dimensions associated with neck pain and disability.
Changes in all of the outcome measures for the second subset of patients were analyzed with a principal components analysis to determine the number of factors involved in the treatment effect. If the changes in the NPAD after treatment indicated changes in pain and disability similar to those of the other measures, then the NPAD should have loaded heavily on a common factor.
RESULTS
Test-retest reliability
Five of the 33 patients in the first sample who filled out the NPAD twice within a week to record their degree of neck pain were not included in the analysis because of missing values. The correlation between the two sets of NPAD scores for the remaining patients with neck pain was strong (r ‫ס‬ 0.97; p <0.01). The reliability coefficient calculated from the data (r 2 ‫ס‬ 0.93) show a high degree of consistency and stability in the NPAD scores.
A similar consistency is apparent in the monthly data from the second sample of patients who were undergoing treatment of chronic pain. Of the 50 patients who had injections of either botulinum toxin or saline during their initial visit to the clinic, 45 completed the 4-month clinical trial, and their data are included in correlations presented in Table 1 . The Neck Pain and Disability Scale scores collected monthly for the same sample of participants were significantly correlated. The correlation between week 1 and week 4 was the lowest, presumably because it coincided with the injections. The correlations for the control group during the last two testing periods may most accurately reflect the repeatability of the NPAD because they were determined at the longest interval after the injections and the data do not include the effect of a drug treatment.
Construct validity
During the 4 months that the research participants were followed, performance on the NPAD indicated a significant decline in pain and disability. Scores were analyzed with a repeated measures ANOVA (F ‫ס‬ 22.11; p <0.01; mean NPAD scores for the first, fourth, eighth, twelfth, and sixteenth week ‫ס‬ 51, 45, 41, 36, and 36). Figure 2 presents the amount of improvement or worsening in the NPAD scores during the 16-week clinical trial for each of the participants. Although the negative change scores showed that the conditions of a few worsened over the 16-week period, most showed sizable improvements, irrespective of treatment condition.
In fact, all of the outcome measures were consistent in showing a significant benefit to treatment with injections (p values <0.05). However, the data on treatment effect size in Table 2 demonstrate considerable variation among the measures. Large effect sizes were found with all of the outcome measures except the GAS. Both patient and physician GASs indicated small effects. The NPAD showed the largest effect size among the outcome measures, and when subdivided into factor scores, factor 2 (pain intensity) and factor 4 (interference in life events) yielded the largest treatment effects.
To demonstrate that the data collected over the 4-month study accurately reflected improvement in the patient's perception of pain and disability, the NPAD changes were correlated with the GASs (measured in week 16), with changes in muscle tenderness as measured by pressure algometry, and with changes in performance on other measures of pain and disability (NDI and PDI). Pearson correlations presented in Table 3 show that the changes in the NPAD are significantly related to all of the other outcome measures.
Evidence of convergent and divergent validity, in particular, was found when the changes in algometer scores taken at trigger and control points were correlated separately. Correlations testing convergent validity were higher than those for divergent validity. Changes in muscle pressure at control points were not found to correlate with either the NPAD total score or any of the factor scores.
Furthermore, to identify measures that might be useful in predicting a treatment effect, all of the variables studied before treatment were entered into a forward stepwise regression analysis of the NPAD changes. The Neck Pain and Disability Scale factor 1 (problems with the neck) was the only measure to predict a significant proportion of the variance (13%).
To determine how many factors were involved in the treatment effect, the changes in the scores on the NPAD, NDI, and PDI and for muscle tenderness and the GASs were analyzed with a principal components analysis. One factor, which represented 66% of the variance, was identified from the results of the Scree test and eigenvalues (in excess of 1.0). Factor loadings (Table 4) show that the changes in the NPAD and the other pain measures loaded heavily on this factor, as did the GASs and the changes in muscle tenderness.
DISCUSSION
The results of the study add to the existing evidence that the NPAD is a reliable and valid instrument for measuring pain and disability caused by or attributed to neck pain. Test-retest reliability was demonstrated by observing two samples of neck pain patients: the first measured twice within a week before treatment and the second measured at 4-month intervals after treatment by injections in painful cervical-shoulder girdle muscles. In all cases, strong correlations were observed between NPAD scores for the same participants across repeated testing, indicating a highly consistent and repeatable instrument. The reliability coefficient indicated minimal measurement error (7%). The NPAD can be relied on to provide a stable measure for patients with neck pain.
Evidence of construct validity was provided when the NPAD was compared with other outcome measures to assess changes in pain and disability after treatment. Changes in the NPAD were significantly correlated with associated changes in muscle tenderness, as measured by pressure algometry and by the patient's and physician's GAS for pain and disability. Convergent and divergent validity were demonstrated when the NPAD changes were found to be correlated with the changes in algometer scores for primary trigger points but not with the changes at control points. Consistent with previous findings, 1 NPAD changes were also found to be correlated with changes in other measures of pain and disability. However, even though all of the measures showed significant treatment effects, effect size data demonstrated that the NPAD provides the most responsive index of the changes in pain perception that follow treatment.
Another advantage of the NPAD in comparison with other pain measures is the comprehensive nature of the instrument. Factor scores derived from the NPAD can be used to indicate whether treatment effects have occurred on each of the underlying dimensions of chronic neck pain. An analysis of the NPAD factor scores showed that although treatment with injections have a significant effect on all four of the underlying factors involved in chronic neck pain, the largest treatment benefit is in the areas of pain intensity and interference with life events. The results of the stepwise regression also suggest that factor scores may have some limited usefulness in predicting treatment success.
When changes in all of the measures after treatment are factor-analyzed, results point to only one underlying factor, and the NPAD changes load heavily on that factor. However, even though the NPAD is similar to both pressure algometry and the patient and physician GASs for evaluating changes in pain and disability that follow treatment of neck pain, the results show that the NPAD is a more responsive and comprehensive measure, and NPAD factor scores have some value for researchers interested in specifying how treatments may influence the varied characteristics of the pain experience. Pain is acknowledged to be a multidimensional experience, and a pain measure that reflects the complex nature of the experience has considerable research utility.
Because this study was conducted in a clinical setting, however, some caution must be used in interpreting the results. Factors that may limit the conclusions are the small samples necessitated by the use of patients with chronic neck pain, confounding of reliability assessment with measures of treatment changes, use of self-reported data, and general loss of control implicit in the use of the correlational method. Future work must ameliorate these limiting factors and document the utility of the multidimensional structure of the NPAD.
